Provision of an explanation for the inefficacy of immunotherapy in sporadic inclusion body myositis: Quantitative assessment of inflammation and ß-amyloid in the muscle.

Zschüntzsch J, Voss J, Creus K, Sehmisch S, Raju R, Dalakas MC, Schmidt J. Provision of an explanation for the inefficacy of immunotherapy in sporadic inclusion body myositis: Quantitative assessment of inflammation and ß-amyloid in the muscle. Arthritis Rheum. 2012 Dec; 64(12):4094-103.

View in: PubMed